☰

Ali Ozuer, Ph.D. - Publications

Affiliations: 
2002 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Chemical Engineering, Biomedical Engineering, Cell Biology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Uchida H, Shah WA, Ozuer A, Frampton AR, Goins WF, Grandi P, Cohen JB, Glorioso JC. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition. Journal of Virology. 83: 2951-61. PMID 19129446 DOI: 10.1128/Jvi.01449-08  0.499
2007 Tsvitov M, Frampton AR, Shah WA, Wendell SK, Ozuer A, Kapacee Z, Goins WF, Cohen JB, Glorioso JC. Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection. Virology. 360: 477-91. PMID 17157347 DOI: 10.1016/J.Virol.2006.10.039  0.513
2006 Jiang C, Ataai M, Ozuer A, Krisky D, Wechuck J, Pornsuwan S, Pourarian F, Glorioso JC. Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention. Biotechnology and Bioengineering. 95: 48-57. PMID 16673413 DOI: 10.1002/Bit.20943  0.657
2005 Krisky DM, Wechuck J, Wolfe D, Huang S, Ozuer A, Glorioso JC. 757. Replication Defective HSV-1 Immediate Early (IE) Gene Mutants: A Comparison of Vector Toxicity Versus Transgene Expression Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.298  0.743
2005 Jiang C, Wechuck J, Ozuer A, Glorioso J, Ataai M. Reducing agents and imidazole protect Hsv-1 vector from inactivation during immobilized cobalt affinity chromatography Aiche Annual Meeting, Conference Proceedings. 12145.  0.562
2004 Wolfe D, Niranjan A, Trichel A, Wiley C, Ozuer A, Kanal E, Kondziolka D, Krisky D, Goss J, Deluca N, Murphey-Corb M, Glorioso JC. Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates. Gene Therapy. 11: 1675-84. PMID 15306839 DOI: 10.1038/Sj.Gt.3302336  0.437
2004 Wolfe D, Wechuck JB, Krisky DM, Goff JP, Goins WF, Ozuer A, Epperly ME, Greenberger JS, Fink DJ, Glorioso JC. Delivery of herpes simplex virus-based vectors to stem cells. Methods in Molecular Biology (Clifton, N.J.). 246: 339-52. PMID 14970603 DOI: 10.1385/1-59259-650-9:339  0.759
2002 Wechuck JB, Ozuer A, Goins WF, Wolfe D, Oligino T, Glorioso JC, Ataai MM. Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors. Biotechnology and Bioengineering. 79: 112-9. PMID 17590937 DOI: 10.1002/Bit.10310  0.715
2002 Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, Ataai MM. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnology Progress. 18: 476-82. PMID 12052062 DOI: 10.1021/Bp010176K  0.738
2002 Ozuer A, Wechuck JB, Goins WF, Wolfe D, Glorioso JC, Ataai MM. Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnology and Bioengineering. 77: 685-92. PMID 11807764 DOI: 10.1002/Bit.10162  0.739
Show low-probability matches.